Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.

Ozawa T, Toba K, Suzuki H, Kato K, Iso Y, Akutsu Y, Kobayashi Y, Takeyama Y, Kobayashi N, Yoshimura N, Akazawa K, Aizawa Y; EPO/AMI-I Pilot Study Researchers.

Circ J. 2010 Jul;74(7):1415-23. Epub 2010 May 22.

PMID:
20501957
[PubMed - indexed for MEDLINE]
Free Article
2.

Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study.

Taniguchi N, Nakamura T, Sawada T, Matsubara K, Furukawa K, Hadase M, Nakahara Y, Nakamura T, Matsubara H.

Circ J. 2010 Nov;74(11):2365-71. Epub 2010 Sep 8.

PMID:
20834185
[PubMed - indexed for MEDLINE]
Free Article
3.

Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial.

Minamino T, Toba K, Higo S, Nakatani D, Hikoso S, Umegaki M, Yamamoto K, Sawa Y, Aizawa Y, Komuro I; EPO-AMI-II study investigators.

Cardiovasc Drugs Ther. 2012 Oct;26(5):409-16. doi: 10.1007/s10557-012-6410-4.

PMID:
22940818
[PubMed - indexed for MEDLINE]
4.

Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III).

Belonje AM, Voors AA, van Gilst WH, Anker SD, Slart RH, Tio RA, Zijlstra F, van Veldhuisen DJ; HEBE III investigators.

Am Heart J. 2008 May;155(5):817-22. doi: 10.1016/j.ahj.2007.12.036.

PMID:
18440327
[PubMed - indexed for MEDLINE]
5.

Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.

Achilli F, Malafronte C, Lenatti L, Gentile F, Dadone V, Gibelli G, Maggiolini S, Squadroni L, Di Leo C, Burba I, Pesce M, Mircoli L, Capogrossi MC, Di Lelio A, Camisasca P, Morabito A, Colombo G, Pompilio G; STEM-AMI Investigators.

Eur J Heart Fail. 2010 Oct;12(10):1111-21. doi: 10.1093/eurjhf/hfq150.

PMID:
20861135
[PubMed - indexed for MEDLINE]
6.

A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.

Yang Z, Zhang F, Ma W, Chen B, Zhou F, Xu Z, Zhang Y, Zhang D, Zhu T, Wang L, Wang H, Ding Z, Zhang Y.

Cardiovasc Ther. 2010 Dec;28(6):380-5. doi: 10.1111/j.1755-5922.2009.00116.x.

PMID:
20337639
[PubMed - indexed for MEDLINE]
7.

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).

Jang IK, Weissman NJ, Picard MH, Zile MR, Pettigrew V, Shen S, Tatsuno J, Hibberd MG, Tzivoni D, Wackers FJ; EVOLVE Investigators.

Am Heart J. 2008 Jan;155(1):113.e1-8. Epub 2007 Nov 1.

PMID:
18082500
[PubMed - indexed for MEDLINE]
8.

COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.

Mansour S, Roy DC, Bouchard V, Nguyen BK, Stevens LM, Gobeil F, Rivard A, Leclerc G, Reeves F, Noiseux N.

J Cardiovasc Transl Res. 2010 Apr;3(2):153-9. doi: 10.1007/s12265-009-9145-2. Epub 2009 Nov 12.

PMID:
20560029
[PubMed - indexed for MEDLINE]
9.

High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study.

Ferrario M, Arbustini E, Massa M, Rosti V, Marziliano N, Raineri C, Campanelli R, Bertoletti A, De Ferrari GM, Klersy C, Angoli L, Bramucci E, Marinoni B, Ferlini M, Moretti E, Raisaro A, Repetto A, Schwartz PJ, Tavazzi L.

Int J Cardiol. 2011 Feb 17;147(1):124-31. doi: 10.1016/j.ijcard.2009.10.028. Epub 2009 Nov 10.

PMID:
19906454
[PubMed - indexed for MEDLINE]
10.

Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

Gao D, Ning N, Niu X, Dang Y, Dong X, Wei J, Zhu C.

Am Heart J. 2012 Nov;164(5):715-727.e1. doi: 10.1016/j.ahj.2012.07.031. Epub 2012 Oct 16. Review.

PMID:
23137502
[PubMed - indexed for MEDLINE]
11.

Still searching for a new therapeutic strategy for acute myocardial infarction.

Saito Y.

Circ J. 2010 Nov;74(11):2290-2. Epub 2010 Oct 16. No abstract available.

PMID:
20962420
[PubMed - indexed for MEDLINE]
Free Article
12.

Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS).

Andreotti F, Agati L, Conti E, Santucci E, Rio T, Tarantino F, Natale L, Berardi D, Mattatelli A, Musumeci B, Bonomo L, Volpe M, Crea F, Autore C.

J Thromb Thrombolysis. 2009 Nov;28(4):489-95. doi: 10.1007/s11239-009-0363-x.

PMID:
19533304
[PubMed - indexed for MEDLINE]
14.

An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study).

Rusnak JM, Kopecky SL, Clements IP, Gibbons RJ, Holland AE, Peterman HS, Martin JS, Saoud JB, Feldman RL, Breisblatt WM, Simons M, Gessler CJ Jr, Yu AS.

Am J Cardiol. 2001 Sep 1;88(5):482-7.

PMID:
11524054
[PubMed - indexed for MEDLINE]
15.

Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.

Ambrosioni E, Borghi C, Magnani B.

Am J Cardiol. 1991 Nov 18;68(14):101D-110D.

PMID:
1746414
[PubMed - indexed for MEDLINE]
16.

Stem cells mobilization in acute myocardial infarction (stem-AMI trial): preliminary data of a perspective, randomized, single blind trial.

Malafronte C, Achilli F.

Minerva Cardioangiol. 2007 Dec;55(6):721-31.

PMID:
18091641
[PubMed - indexed for MEDLINE]
17.

Recombinant human erythropoietin in the treatment of acute ischemic stroke.

Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jähnig P, Herrmann M, Knauth M, Bähr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C; EPO Stroke Trial Group.

Stroke. 2009 Dec;40(12):e647-56. doi: 10.1161/STROKEAHA.109.564872. Epub 2009 Oct 15.

PMID:
19834012
[PubMed - indexed for MEDLINE]
Free Article
18.

[Left ventricular function in gated single photon emission computed tomography (GSPET) in patients with myocardial infarction subjected to thrombolysis or primary PTCA].

Zachorski M, Dziuk M, Pietrzykowski J, Rdzanek H, Kamiński G, Cholewa M, Kubik L.

Pol Merkur Lekarski. 2005 Apr;18(106):376-9. Polish.

PMID:
16161914
[PubMed - indexed for MEDLINE]
19.

Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.

Théroux P, Grégoire J, Chin C, Pelletier G, de Guise P, Juneau M.

J Am Coll Cardiol. 1998 Sep;32(3):620-8.

PMID:
9741502
[PubMed - indexed for MEDLINE]
Free Article
20.

Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.

Bassand JP, Cassagnes J, Machecourt J, Lusson JR, Anguenot T, Wolf JE, Maublant J, Bertrand B, Schiele F.

Circulation. 1991 Sep;84(3):1107-17.

PMID:
1909218
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk